The hospital costs of care for stroke in nine European countries

Health Economics
David EpsteinAndrea Manca

Abstract

Stroke is a major cause of mortality and morbidity, but the reasons for differences in costs of care within and between countries are not well understood. The HealthBASKET project used a vignette methodology to compare the mean costs and prices of hospital care across providers in nine European Union countries. Data on resource use, unit costs and prices of care for female stroke patients without co-morbidity were collected from a sample of 50 hospitals. Mean costs for each provider were analysed using multiple regression. Sensitivity analysis explored the effects on cost of using official exchange rates, purchasing power parity (PPP) and proportion of national income per capita. The mean cost of a hospital episode per patient for stroke at PPP was 3813 euros (standard error 227) with an additional day in hospital typically associated with 6.9% (95% CI: 4-9%) higher costs and thrombolysis associated with 41% higher costs (10-73%). After adjusting for explanatory factors, about 76% of the variation in cost could be attributed to between-country differences, and the extent of this variation was sensitive to the method of currency conversion. There was considerable variation in the care pathways within and between countries, inclu...Continue Reading

References

Nov 1, 1996·Stroke; a Journal of Cerebral Circulation·R BeechC Wolfe
Jul 7, 2001·Stroke; a Journal of Cerebral Circulation·R GrieveC D Wolfe
Mar 5, 2003·Age and Ageing·Helen RodgersUNKNOWN British Association of Stroke Physicians
Oct 24, 2003·Lancet Neurology·Catharina J M KlijnUNKNOWN American Stroke Association and European Stroke Initiative
Oct 27, 2004·Age and Ageing·A BhallaUNKNOWN BIOMED II European Study of Stroke Care
Jul 14, 2005·Journal of Evaluation in Clinical Practice·P IrwinA G Rudd
Feb 24, 2006·European Heart Journal·José LealMike Rayner

❮ Previous
Next ❯

Citations

Jan 13, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·M PirsonP Leclercq
Mar 26, 2013·Seminars in Ultrasound, CT, and MR·Ana Ortiz de MendivilJosé M Millán
Jan 3, 2013·Acta Neurologica Scandinavica·J C BouvyD W J Dippel
Sep 20, 2012·Health Economics·Mikko Peltola, UNKNOWN EuroDRG group
May 16, 2009·Topics in Stroke Rehabilitation·Lalit Kalra, Marion F Walker
May 27, 2015·Health Policy·Victor BystrovTomasz Hermanowski
Jan 14, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Siok Swan TanLeona Hakkaart-van Roijen
May 19, 2010·Revue neurologique·F YekhlefA Ollivier
Jun 6, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anna RingborgPeter Lindgren
Mar 3, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Z AdemiC M Reid
Apr 7, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Raymond OppongUNKNOWN GRACE-01 Study Team
Dec 22, 2020·Frontiers in Public Health·László LorenzoviciPéter Gaál

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.